GlaxoSmithKline Intellectual Property Development Limited
发明人:
Charnley, Adam Kenneth,Darcy, Michael G.,Dodson, Jason W.,Dong, Xiaoyang,Hughes, Terry V.,Kang, Jianxing,Leister, Lara Kathryn,Lian, Yiqian,Li, Yue,Mehlmann, John F.,Nevins, Neysa,Ramanjulu, Joshi M,
申请号：
AU2020200692
公开号：
AU2020200692B2
申请日:
2020.01.30
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020200692B220200827.pdf#####C: Interwo n NRPortbl DCC SXD 19811368_l.docx-30/01/2020 ABSTRACT Disclosed are compounds having the formula: 5 R 4 3 N R R NH NsN N-N RA1 RB1 R 15 Rc1 (A)q (B)r (C) RB 2 I RC2 N RI / NH NsN R 6 O R 17 R 16 (I-N) whereinq,r,s,A,B,C,RARA2,RB, RB2 ,R Rc 2, R3,R 4, RR6, R 4, R 5, R 6, and R", are as defined herein, or a tautomer thereof, or a salt, particularly a 10 pharmaceutically acceptable salt, thereof.
